MX343701B - Procedimiento para alquinilar 17-cetoesteroides 16-sustituidos. - Google Patents

Procedimiento para alquinilar 17-cetoesteroides 16-sustituidos.

Info

Publication number
MX343701B
MX343701B MX2014007761A MX2014007761A MX343701B MX 343701 B MX343701 B MX 343701B MX 2014007761 A MX2014007761 A MX 2014007761A MX 2014007761 A MX2014007761 A MX 2014007761A MX 343701 B MX343701 B MX 343701B
Authority
MX
Mexico
Prior art keywords
alkynylating
substituted
keto steroids
steroids
methylene
Prior art date
Application number
MX2014007761A
Other languages
English (en)
Other versions
MX2014007761A (es
Inventor
Gerardo Gutiérrez Fuentes Luis
Miguel Sandoval Rodríguez Celso
Original Assignee
Crystal Pharma Sau
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crystal Pharma Sau filed Critical Crystal Pharma Sau
Publication of MX2014007761A publication Critical patent/MX2014007761A/es
Publication of MX343701B publication Critical patent/MX343701B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
    • C07J7/0055—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/0075—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified substituted in position 17 alfa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/009—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by only one oxygen atom doubly bound

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a un procedimiento para etinilar 16-metilen-17-cetoesteroides para dar los correspondientes 16-metjlen-17a-etjnjl-17ß-hidroxiesteroides mediante tratamiento con acetiluros de litio protegidos con sililo seguido por desililación adicional. Los productos resultantes son productos intermedios útiles en la preparación de varios principios farmacéuticamente activos, tales como por ejemplo Nestorone(r) o acetato de melengestrol.
MX2014007761A 2011-12-23 2012-12-19 Procedimiento para alquinilar 17-cetoesteroides 16-sustituidos. MX343701B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161580010P 2011-12-23 2011-12-23
EP11382395 2011-12-23
PCT/EP2012/076095 WO2013092668A1 (en) 2011-12-23 2012-12-19 Process for alkynylating 16-substituted-17-keto steroids

Publications (2)

Publication Number Publication Date
MX2014007761A MX2014007761A (es) 2015-06-05
MX343701B true MX343701B (es) 2016-11-16

Family

ID=48667748

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014007761A MX343701B (es) 2011-12-23 2012-12-19 Procedimiento para alquinilar 17-cetoesteroides 16-sustituidos.

Country Status (10)

Country Link
US (1) US9296780B2 (es)
EP (1) EP2794632B1 (es)
JP (1) JP6100798B2 (es)
KR (1) KR102028221B1 (es)
CN (2) CN104093732A (es)
CA (1) CA2859852C (es)
ES (1) ES2576231T3 (es)
HU (1) HUE027821T2 (es)
MX (1) MX343701B (es)
WO (1) WO2013092668A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3189063B1 (en) 2014-09-02 2019-08-14 California Institute of Technology Base-catalyzed silylation of terminial alkyne c-h bonds
CN106928302B (zh) * 2017-03-30 2019-02-22 浙江医药股份有限公司昌海生物分公司 一种雄烯二酮衍生物及其制备方法和应用
US10632066B1 (en) 2019-02-01 2020-04-28 The Population Council, Inc. Method of providing birth control
US11529308B2 (en) 2019-06-21 2022-12-20 The Population Council, Inc. System for providing birth control
US10918649B2 (en) 2019-06-21 2021-02-16 The Population Council, Inc. System for providing birth control

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2272131A (en) 1937-07-22 1942-02-03 Ciba Pharm Prod Inc Nuclear ketones of the cyclopentanopolyhydrophenanthrene series and process of making same
US2723280A (en) 1953-08-27 1955-11-08 Leo Pharm Prod Ltd 1-methyl-17-ethinyl-estradiol
US2843609A (en) 1955-10-11 1958-07-15 Searle & Co 17-alkenyl and alkynyl derivatives of 4-estrene-3, 17-diol
US2877240A (en) 1958-06-09 1959-03-10 Upjohn Co 6-fluoro-17beta-hydroxy-17alpha-lower aliphatic hydrocarbon-1, 4-androstadienes and 6-fluoro-17alpha-lower aliphatic hydrocarbon estradiols
US3166551A (en) 1962-01-02 1965-01-19 British Drug Houses Ltd Process for the preparation of 3-oxo-delta4-6-methyl steroids
GB1058543A (en) 1963-03-13 1967-02-15 Organon Labor Ltd 16-methylene-steroids
BE652906A (es) 1963-09-11
US3262950A (en) * 1963-12-17 1966-07-26 Syntex Corp 16-methylene-21-halo-19-nor-deta4, 6-pregnadienes
NL6513663A (es) * 1965-10-22 1967-04-24
US3470217A (en) 1966-04-07 1969-09-30 Syntex Corp Process for the preparation of alkynyl carbinols
CH515226A (de) 1968-05-06 1971-11-15 Ciba Geigy Ag Herstellung neuer 6-Fluorsteroide der Androstanreihe
US3516991A (en) 1968-09-19 1970-06-23 Upjohn Co Chemical process
CH547268A (de) * 1968-10-25 1974-03-29 Merck Patent Gmbh Verfahren zur herstellung von n-disubstituierten 3-amino3,5-dien-19-nor-steroiden.
US3704253A (en) 1970-09-23 1972-11-28 American Home Prod 13 - polycarbonalkyl - 16 - methylgona-1,3,5(10)-trienes and 13-polycarbonalkyl-16-methylgon - 4 - en-3-ones and intermediates for their production
US3755382A (en) * 1972-06-01 1973-08-28 Stanford Research Inst Synthesis of 17alpha-(trimethylsilylethynyl)estradiol
US3927046A (en) 1972-12-09 1975-12-16 Akzona Inc Novel 11,11-alkylidene steroids
US4055562A (en) 1975-10-06 1977-10-25 Sterling Drug Inc. Process for preparing pregn-20-yne compounds and novel product produced thereby
US4041055A (en) 1975-11-17 1977-08-09 The Upjohn Company Process for the preparation of 17α-hydroxyprogesterones and corticoids from androstenes
CH642936A5 (de) 1979-10-19 1984-05-15 Hoffmann La Roche Aethinylierung alpha,beta-ungesaettigter ketone.
US4416821A (en) 1982-02-17 1983-11-22 The Upjohn Company Process for preparing 16-methylene steroids
US4567001A (en) 1982-09-20 1986-01-28 The Upjohn Company 16-Methylene-17α-hydroxy-progesterones
JPS5976100A (ja) * 1982-09-20 1984-04-28 ジ・アツプジヨン・カンパニ− １６−メチレン−１７α−ヒドロキシ−プロゲステロン
EP0179496A1 (en) * 1982-09-20 1986-04-30 The Upjohn Company 16-Sulfinylmethyl-steroids, their preparation and use
EP0402963B1 (en) * 1984-01-05 1997-05-07 PHARMACIA & UPJOHN COMPANY 17-Alpha ethynyl steroids
US4614621A (en) * 1984-04-20 1986-09-30 The Upjohn Company Ethynylation of 16-methylene-17-keto steroids
PT85891B (pt) * 1986-10-10 1990-07-31 Roussel Uclaf Processo para a preparacao de 9-alfa-hidroxi-esteroides e dos respectivos derivados 9(11)-deidro bem como de composicoes farmaceuticas que os contem
US5502183A (en) * 1992-01-28 1996-03-26 Schering Corporation Steroid intermediates and processes for their preparation
HU216828B (hu) * 1995-12-22 1999-09-28 Richter Gedeon Vegyészeti Gyár Rt. Szteránvázas vegyületek, eljárás ezek előállítására, az ezeket tartalmazó gyógyászati készítmények és intermedierjeik
JP4815083B2 (ja) * 1999-08-31 2011-11-16 メルク・シャープ・エンド・ドーム・コーポレイション 複素環化合物およびそれの使用方法
EP1689768A2 (en) * 2003-11-24 2006-08-16 Merck & Co., Inc. Estrogen receptor modulators
US20070015750A1 (en) * 2005-04-14 2007-01-18 Stefan Baeurle Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
US20090012321A1 (en) 2007-06-06 2009-01-08 Klaus Annen Process for preparing 17alpha-acetoxy-6-methylenepregn-4-ene-3,20-dione, medroxyprogesterone acetate and megestrol acetate
PL2300489T3 (pl) * 2008-06-06 2016-11-30 Sposoby wytwarzania 17-alkinylo-7-hydroksysteroidów i związków pokrewnych

Also Published As

Publication number Publication date
CA2859852C (en) 2020-09-15
CA2859852A1 (en) 2013-06-27
JP2015500857A (ja) 2015-01-08
WO2013092668A1 (en) 2013-06-27
HUE027821T2 (en) 2016-11-28
JP6100798B2 (ja) 2017-03-22
US9296780B2 (en) 2016-03-29
EP2794632A1 (en) 2014-10-29
US20150005518A1 (en) 2015-01-01
CN104093732A (zh) 2014-10-08
CN107955052A (zh) 2018-04-24
MX2014007761A (es) 2015-06-05
KR102028221B1 (ko) 2019-10-02
CN107955052B (zh) 2024-07-05
KR20140130425A (ko) 2014-11-10
EP2794632B1 (en) 2016-03-16
ES2576231T3 (es) 2016-07-06

Similar Documents

Publication Publication Date Title
MY173877A (en) Branched 3-phenylpropionic acid derivatives and the use thereof
MD20150091A2 (ro) Compuşi antivirali
PL2791093T3 (pl) Sposób wytwarzania 2,3,3,3-tetrafluoropropenu
EA033455B1 (ru) Кристаллические формы замещенных 5-фтор-1h-пиразолопиридинов, способы их получения, их применение для получения лекарственного средства, лекарственное средство и способ лечения на их основе
WO2012156998A3 (en) Amorphous mirabegron and processes for crystal forms of mirabegron
MX362271B (es) Nueva forma cristalina de ciclosporina a, metodos de preparacion y metodos para su uso.
HK1200367A1 (en) 4-pregenen-11ss-17-21-triol-3, 20-dione derivatives for the treatment of ocular conditions 4--11ss-17-21--320-
TN2014000001A1 (en) A new therapeutical composition containing apomorphine as active ingredient
PH12014501195A1 (en) Novel 2h-indazoles as ep2, receptor antagonists
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
MX359670B (es) Proceso para preparar productos que comprenden activos estabilizados y composiciones que los comprenden.
MX343701B (es) Procedimiento para alquinilar 17-cetoesteroides 16-sustituidos.
IN2014DN06964A (es)
WO2012131707A3 (en) Crystalline form of bortezomib, preparation method and pharmaceutical composition there f
MX2014004083A (es) Metodo para aislar ingenol.
HK1199242A1 (zh) 生產 -丁二烯的方法
WO2015023508A3 (en) Methods for improving asthma symptoms using benralizumab
WO2012148148A3 (en) Novel zinc azide complex and a process for preparing tetrazole derivatives using the same
MY164880A (en) Process for the preparation of isoxazolyl-methoxy-nicotinic acids
UA109804C2 (xx) 2-метоксипіридин-4-ільні похідні
WO2011157670A3 (en) Process for the preparation of benzamide derivatives
WO2012122513A3 (en) Generation of anti-fn14 monoclonal antibodies by ex-vivo accelerated antibody evolution
WO2012159981A3 (en) PROCESS FOR THE PREPARATION OF α-SUBSTITUTED KETONES AND THEIR APPLICATION IN SYNTHESIS OF PHARMACEUTICALLY ACTIVE COMPOUNDS
MX351994B (es) Formas cristalinas de [(s)-1-carbamoil-2-(feniil-pirimidin-2-il-am ino)-etil]-amida del acido 2-(2-metilamino-pirimidin-4-il)-1h-indo l-5-carboxilico.
WO2013046233A3 (en) Process for the preparation of octreotide acetate

Legal Events

Date Code Title Description
FG Grant or registration